LivaNova PLC (LIVN) Stock Analysis
A live, multi-source view of LivaNova PLC (LIVN): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers.
Sector: Healthcare · Industry: Medical Devices · United Kingdom · 3,300 employees · livanova.com
Key statistics · as of 2026-09-05
As of 2026-09-05, LivaNova PLC (LIVN) had a market capitalization of $4.50B, a trailing P/E of 24.2 (forward 17.5) and a beta of 0.87; the shares traded in a 52-week range of $48.82 – $85.76 (40.5% over the year).
- Market cap
- $4.50B
- Enterprise value
- $4.35B
- Trailing P/E
- 24.2
- Forward P/E
- 17.5
- PEG ratio
- 0.93
- Price / book
- 3.40
- EPS (trailing)
- $3.39
- EPS (forward)
- $4.68
- Payout ratio
- 0.0%
- 52-week range
- $48.82 – $85.76
- 52-week change
- 40.5%
- Beta
- 0.87
- Average volume
- 700,039
- Shares outstanding
- 54.9M
- Short % of float
- 9.84%
- Profit margin
- 12.8%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-08
In RapidTradeView’s 2026-09-08 scan of the US universe, LivaNova PLC (LIVN) last closed at $81.92 (the last completed close before that scan).
Technicals at the scan: RSI 56 (neutral territory), price +2.2% versus its 20-day average, 20-day versus 50-day average spread -0.7%, MACD histogram 0.25.
Sentiment inputs: 67% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish; analyst consensus score 75/100.
Next scheduled company event: in 57 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of LIVN; corporate insiders filed 0 buys and 1 sell (1 filer, latest disclosure 2026-08-13). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Ahmet Tezel (0B/1S). Who is trading what
RapidTradeView pick record
LIVN has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls LivaNova PLC (LIVN) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell LIVN.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.